Blood tests study to track circulating vessel cells in sepsis
Part of Infections clinical trials.
This study collects information from the blood of people in intensive care, to better understand what is happening in the body during sepsis or serious infection. It may help researchers find ways to monitor disease and improve care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You are currently admitted to an intensive care unit (with or without sepsis).
- You have French national health insurance.
- You can agree to join the study and your decision is not being blocked (or you were able to consent before a closed process).
- You are not under legal protection and not enrolled in the country’s national medical help program.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
This study looks at blood vessel cells in three groups: healthy adults, patients having major surgery, and critically ill patients with sepsis. It aims to understand how these cells change in different types of inflammation.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This trial is testing a new approach to understand how sepsis (a severe infection) damages blood vessels. It looks at tiny particles released by cells and a protein called PLIN3 to see if they can help protect blood vessels in patients with sepsis.
Hear when a new Critical Illness With or Without Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.